Bailard Inc. Makes New $322,000 Investment in AdaptHealth Corp. (NASDAQ:AHCO)

Bailard Inc. purchased a new position in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 29,700 shares of the company's stock, valued at approximately $322,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in AHCO. SummerHaven Investment Management LLC boosted its position in shares of AdaptHealth by 1.7% during the 1st quarter. SummerHaven Investment Management LLC now owns 79,883 shares of the company's stock valued at $866,000 after acquiring an additional 1,329 shares during the last quarter. Guggenheim Capital LLC boosted its position in shares of AdaptHealth by 10.1% during the 4th quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock valued at $158,000 after acquiring an additional 1,525 shares during the last quarter. Sterling Capital Management LLC boosted its position in shares of AdaptHealth by 5.2% during the 4th quarter. Sterling Capital Management LLC now owns 33,558 shares of the company's stock valued at $319,000 after acquiring an additional 1,644 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of AdaptHealth by 3.6% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 57,931 shares of the company's stock valued at $552,000 after acquiring an additional 1,999 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. boosted its position in shares of AdaptHealth by 6.8% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 32,797 shares of the company's stock valued at $356,000 after acquiring an additional 2,081 shares during the last quarter. 82.67% of the stock is currently owned by institutional investors.

AdaptHealth Stock Up 3.6%

Shares of AdaptHealth stock traded up $0.33 during trading on Tuesday, hitting $9.48. 1,426,306 shares of the stock traded hands, compared to its average volume of 1,335,112. The company has a current ratio of 1.29, a quick ratio of 1.07 and a debt-to-equity ratio of 1.25. AdaptHealth Corp. has a 52-week low of $7.11 and a 52-week high of $11.90. The stock's fifty day simple moving average is $8.99 and its 200 day simple moving average is $9.39. The firm has a market cap of $1.28 billion, a P/E ratio of 16.63, a price-to-earnings-growth ratio of 1.07 and a beta of 1.63.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on AHCO shares. Royal Bank Of Canada lowered their price target on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a research report on Thursday, May 8th. Truist Financial lowered their price target on AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a research report on Monday, May 12th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $13.40.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.